Constitutive Activation of gp130 in T Cells Results in Senescence and Premature Aging
Authors:
- Puyan RafiiPRPuyan Rafii
- Friedrich ReusswigFRFriedrich Reusswig
- Julia WernerJWJulia Werner
- Philpp A LangPLPhilpp A Lang
- Stefan Rose-JohnSRStefan Rose-John
- Simone GorressenSGSimone Gorressen
- Christina AlterCAChristina Alter
- Diran HerebianDHDiran Herebian
- Doreen M. FlossDFDoreen M. Floss
- Margitta ElversMEMargitta Elvers
- Roland P. PiekorzRPRoland P. Piekorz
- 14 April 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (11) , 1641-1652
Abstract
IL-6 family members contribute to host defense through the stimulation of acute-phase signaling, hematopoiesis, immune reactions, and regenerative processes. To investigate essential mechanisms that are linked toward a constitutively activated gp130 signaling, we generated and characterized a mouse model that reflects a constitutive and cytokine-independent activation of JAK/STAT3 signaling by Lgp130 in CD4- and CD8-positive T cells. Lgp130 is an engineered form of gp130 in which dimerization and activation are forced by a leucine zipper. T cell–specific Lgp130 activation resulted in massive phenotypical abnormalities, including splenomegaly, lymphadenopathy, and an upregulation of innate immune system components shown by hyperinflammatory signatures in several organs. Moreover, T cell–restricted expression of Lgp130 resulted in increased numbers of cytotoxic and regulatory T cells, especially in lymph nodes. Consistent with this, we found an elevated platelet production and increase in megakaryocytes in the spleen and bone marrow that are causative for an acute thrombocytosis accompanied by anemia. Due to a shortened life span of T cell–specific Lgp130 mice, we could also show that next to an overall increase in regulatory cell-cycle genes, an activation of p53 and increased expression of p21 provide evidence for a senescence-like phenotype. Together, these data suggest that T cell–restricted gp130 activation is not only involved in autoimmune processes but also in senescence-associated aging. Therefore, Lgp130 expression in T cells might be a suitable model to study inflammation and disease.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB1116)
- Deutsche Forschungsgemeinschaft (RTG1949)
- Jürgen Manchot Stiftung (MOI IV)
- Deutsche Forschungsgemeinschaft (EL651/8-1)
This publication has 61 references indexed in Scilit:
- Impact of Interleukin-6 in Hematological MalignanciesTransfusion Medicine and Hemotherapy, 2013
- TNF inhibitor therapy for rheumatoid arthritisBiomedical Reports, 2012
- STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaBlood, 2012
- Plasticity and cross-talk of Interleukin 6-type cytokinesCytokine & Growth Factor Reviews, 2012
- Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription 3 expression in systemic lupus erythematosus patientsRheumatology, 2011
- gp130 at the nexus of inflammation, autoimmunity, and cancerJournal of Leukocyte Biology, 2010
- Bile Acids and Metabolic RegulationDiabetes Care, 2009
- Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine networkProceedings of the National Academy of Sciences, 2009
- Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem CellsMolecular Biology of the Cell, 2006
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997